Skip to content
Review Open access

Direct RNA Targeting by CRISPR/Cas12: Emerging Mechanisms and Diagnostic Applications.

Oct 2026 · Critical reviews in analytical chemistry · pp. 1-15 · 0 citations · 53 references
Medicine

TL;DR

The emerging functional diversity of RNA-responsive Cas12 systems, including Cas12a, Cas12a2, Cas12a3, Cas12f, and Cas12g, are summarized and their underlying mechanisms for direct RNA sensing are discussed, alongside key challenges and future opportunities for clinical translation and point-of-care testing.

Abstract

RNA detection is essential for molecular diagnostics because it provides dynamic information on gene expression, pathogen activity, and disease progression. Conventional RNA detection methods, particularly reverse transcription polymerase chain reaction (RT-PCR), remain widely used but require RNA-to-DNA conversion, thermal cycling, and relatively complex workflows, limiting their suitability for rapid and point-of-care testing. In CRISPR diagnostics, Cas13 has traditionally been regarded as the major RNA-targeting system, whereas Cas12 enzymes have been primarily recognized as DNA-targeting nucleases. Recent studies, however, have revealed that several Cas12 variants can directly recognize RNA targets, enabling reverse-transcription-free RNA detection through mechanisms such as RNA-triggered DNase activity. In this review, we summarize the emerging functional diversity of RNA-responsive Cas12 systems, including Cas12a, Cas12a2, Cas12a3, Cas12f, and Cas12g, and discuss their underlying mechanisms for direct RNA sensing. We further highlight strategies for enhancing Cas12-mediated RNA detection, including guide and activator engineering, nanomaterial-assisted readouts, and autocatalytic signal amplification. Finally, we discuss its applications in infectious disease diagnosis, cancer biomarker detection, and environmental monitoring, alongside key challenges and future opportunities for clinical translation and point-of-care testing.

Read PDF

Similar papers

Review Nov 2026

CRISPR-Cas Assays for Protein Detection: Strategies and Clinical Applications.

Measurement of protein biomarkers with high accuracy is critical for disease diagnostics and prognostic monitoring. However, conventional analytical platforms for protein detection suffer from insufficient sensitivity for low-abundance targets and require time-consuming, multi-step workflows. The CRISPR-Cas system is e...

Shao-Kun Dong, Shuai Zhao, Jin-Qi Deng et al. · 0 citations
Oct 2026

Exonuclease-gated CRISPR/Cas12a biosensing strategy for sensitive detection of lncRNA MIR155HG.

Long non-coding RNAs (lncRNAs) have been shown to be important regulatory factors in initiation and progression of cancer. However, sensitive detection of lncRNAs remains challenging due to their low abundance, complex structure and susceptibility to nuclease degradation. Among various lncRNAs, MIR155HG has been shown...

Qiu-Feng Wang, Yong-Liang Cai, Shi-Yu Zhu et al. · 0 citations
Review Open access Sep 2026

CRISPR-CAS GENOME EDITING AND MOLECULAR DIAGNOSTICS: EMERGING PERSPECTIVES IN GENETICS AND BIOCHEMICAL RESEARCH

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and their associated (Cas) proteins have progressed from an obscure, unannotated repeat sequence first noted in Escherichia coli in 1987 to one of the most versatile toolkits in modern genetics and biochemistry. This chapter provides an expanded, detail...

P. M, R. Sathya, G. P. et al. · 0 citations
#gene editing Open access Sep 2026

In vitro validation of a CRISPR/Cas9 guide RNA targeting COL1A1 gene by cleavage assay.

Functional validation of the gRNAs designed to target exon 2 of the COL1A1 gene is confirmed through in vitro cleavage activity and support its candidate selection for subsequent cellular studies targeting COL1A1, representing an initial step toward future knockout-style cellular models of Osteogenesis Imperfecta.

D. M. Melo, Sabrina Rodrigues Sarquis, Paolla Manzoli Luz et al. · 0 citations
Oct 2026

Ligation-assisted DNA strand displacements and CRISPR/Cas14 cleavage for ultrasensitive detection of PIWI-interacting RNA.

PIWI-interacting RNA (piRNA) as a type of small non-coding RNA holds great promise for managing disease occurrence and progression. Herein, we construct a ligation-assisted DNA strand displacement strategy for enhanced CRISPR/Cas14 cleavage, which provides remarkable SERS and electrochemical responses to indicate trace...

Xiao-Qiang Li, Zhen-Zhen Guo, Wei-Feng Ye et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.